A Limulus amoebocyte lysate gel-clotting method for the determination of endotoxin in a small-volume parenteral product has been described. Sample dilution with 0.1 M potassium phosphate monobasic buffer (pH 8.0) effectively eliminated assay interference, whereas dilution with water did not. The threshold pyrogenic dose for Escherichia coli EC-2 and 0127:B8 endotoxins was determined to be 1.0 ng of endotoxin per kg of body weight. Not more than 1.0 ng of endotoxin (the threshold pyrogenic dose) per the highest recommended human dose or the USP pyrogen test dose per kg of body weight, whichever dose is more stringent, is a logical limit for the quantity of bacterial endotoxin in small-volume parenteral products. Excellent correlation was attained when this criterion was used to compare the Limulus amoebocyte lysate assay with the USP pyrogen test.
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Limulus amoebocyte lysate (LAL), an aqueous extract of amoebocytes from the horseshoe crab, Limulus polyphemus, reacts with endotoxin to form a gel or a clot (7) . Under standardized conditions, this reaction detects picogram quantities of endotoxin. The clotting reaction is triggered when the LAL reagent comes in contact with the lipopolysaccharide (endotoxin) fraction of the cell wall of gramnegative bacteria. The endotoxin activates an enzyme in the LAL reagent which then reacts with a low-molecular-weight clottable protein to form a gel (17) .
Testing by LAL is expeditious, specific, and convenient. The (8, 9, 14) . This paper describes development of LAL methodology for a small-volume parenteral product containing spectinomycin. Pyrogenic dose determination. To correlate the results of the LAL test with the USP pyrogen test, the threshold pyrogenic dose (TPD) was statistically determined by use of the USP pyrogen test. A group of 86 rabbits was injected with five graded doses of E. coli 0127:B8 endotoxin: 0.5, 1.0, 5.0, 10.0, and 30.0 ng per ml of sterile sodium chloride solution per kg of rabbit body weight. To determine the TPD for the United States reference endotoxin, lot EC-2, 71 rabbits were similarly administered graded doses of EC-2 in saline. Body temperatures were recorded at hourly intervals for a minimum of 3 h after injection as outlined by the USP pyrogen test (15) .
MATERIALS AND METHODS
The average febrile response for each dose was a linear function of the natural logarithm of the endotoxin dose. The average pyrogenic dose (APD) was calculated as the dose at which the rabbits tested responded with average temperature increases of 0.4625°C. This value, 0.4625°C, was derived from the most stringent definition of pyrogenicity (3.7°C for eight rabbits), defined by the United States Pharmacopeia (15) . The TPD, defined as the lower 95% confidence interval of the APD, was calculated from the linear regression analysis.
RESULTS AND DISCUSSION TPD. Both the USP pyrogen test and the LAL assay can be used to detect endotoxins; however, only the LAL test can rapidly and precisely quantify endotoxin levels. The minimum quantity of endotoxin that is pyrogenic in rabbits, the TPD, must be determined so that the LAL assay can be correlated with the rabbit data.
Humans and rabbits are reported to respond equally on a per-kilogram-of-body weight basis to threshold pyrogenic quantities of endotoxin (2, 6) . Thus, the minimum quantity of endotoxin that is pyrogenic to humans, the TPD, can be determined by the USP pyrogen test (15) .
A graph of the natural logarithm of the endotoxin (E. coli 0127:B8) dose versus the average febrile response of the 86 rabbits is presented in Fig. 1 (12) . Some drugs also interfere with the LAL test, necessitating dilution or other modification to eliminate interference (8, 9, 14) . Samples of spectinomycin were initially diluted with sterile water for injection at a final concentration of 50 mg of spectinomycin per ml, the level employed for USP pyrogen testing. The pH of these samples was adjusted with pyrogen-free NaOH to a range of between 6 and 8. The samples were then spiked with 0.05 and 0.10 ng of endotoxin per ml of sample preparation. In all cases, the formation of a gel was inhibited, even though the LAL reagent was capable of detecting less than 0.05 ng of endotoxin per ml. The interference may be due to high Na+ content in the testing sample, since these samples required relatively large amounts of NaOH for neutralization. Sullivan and Watson (13) stated that NaCl concentrations greater than 0.154 N decrease the sensitivity of the lysate.
Dilutions of spectinomycin were next prepared in 0.1 M potassium phosphate monobasic buffer. The samples were spiked with graded doses of the E. coli endotoxin and tested by LAL (Table 1) . Since the gelation endpoint of the endotoxin in the sample containing 80 mg of spectinomycin per ml matched the endpoint of endotoxin in the buffer, the interference shown with the LAL test in sterile water for injection was eliminated. Complete inhibition of gelation occurred for the samples containing 90 and 100 mg of spectinomycin per ml. Since the concentration of spectinomycin employed for USP pyrogen testing in rabbits is 50 mg of spectinomycin per ml, this concentration was selected for LAL testing.
Correlation of the LAL test with the USP pyrogen test. Thirty-five lots of spectinomycin were tested by LAL at 50 mg of spectinomycin per ml of 0.1 M potassium phosphate monobasic buffer. Two sets of positive controls were prepared for each lot by spiking the samples with 0.05 and 0.10 ng of the E. coli endotoxin standard per ml. In all cases, the lowest spiked level of endotoxin promoting a gel was the 0.05-ng/mlspiked positive control.
USP criterion. Determining the effects of spectinomycin on the pyrogenicity of endotoxin was also necessary to evaluate possible product synergism or inhibition. Solutions of spectinomycin were prepared at the USP and LAL testing concentration of 50 mg of spectinomycin per ml of sterile sodium chloride solution, spiked with graded doses of E. coli lipopolysaccharide (0.5, 1.0, and 5.0 ng of endotoxin per ml of solution), and administered to the rabbits according to the USP pyrogen test (15) . Eight rabbits were tested at each dose level, and two such pyrogen assays were performed, resulting in a group of 48 rabbits tested.
The data obtained were similar and could be statistically pooled. A graph of the natural logarithm of the endotoxin dose versus the average febrile response is presented in Fig. 3 . From the linear regression analysis, the APD was calculated to be 1.19 ng of endotoxin per kg of body weight. A comparison of these statistics with those of the endotoxin in sterile sodium chloride solution (APD = 1.43 ng of endotoxin per kg of body weight) (Fig. 1) indicates that spectinomycin administered in a dose of 50 mg/kg does not influence the pyrogenic activity of the endotoxin.
Endotoxin limits. The USP pyrogen test was designed to mimic the administration of the human dose (milligrams of a drug per kilogram of body weight) per injection. However, drugs are pharmacologically active compounds, and some must be diluted for testing by the USP pyrogen test to avoid rabbit sensitivity. Quite often, requirements for such dilutions are so extensive that the rabbit dose is several-fold less concentrated than the human dose.
When applied to small-volume parenteral products, an endotoxin limit should control the total, absolute quantity of endotoxin a patient receives per injected dose rather than the endotoxin per milliliter of drug solution, since the febrile response is a function of the quantity of endotoxin injected per kilogram of body weight (1, 2, 10) . Administering a constant amount of endotoxin, 2 ng of E. coli 0127:B8 endotoxin per kg of body weight, in varying volumes of saline confirmed that the febrile responses of the rabbits were similar regardless of the injection volume ( Table 3 ). The febrile responses were a function of the total, absolute quantity of endotoxin injected per kilogram of body weight. Thus the limit of endotoxin should be based on the total quantity of endotoxin a patient receives per injection dose, e.g., the TPD, rather than the endotoxin concentration, i.e., nanograms of endotoxin per milliliter, as proposed by the The TPD has been defined as 1.0 ng of endotoxin (United States E. coli reference endotoxin lot EC-2) per kg of body weight. Greisman and Hornick reported that humans and rabbits respond equally on a per-kilogram-of-body weight basis to threshold pyrogenic quantities of endotoxin, and that the TPD of E. coli endotoxin for both humans and rabbits is 1.0 ng/kg of body weight (2) . The highest recommended intramuscular adult dose of spectinomycin is 4 g (11) , or approximately 60 mg of spectinomycin per kg per injection, assuming an average human body weight of 70 kg. The limit of endotoxin, which is expressed in terms of the human dose rather than the lower USP pyrogen test dose, is thus 1.0 ng of endotoxin per 60 mg of spectinomycin.
The results of this study, as well as of those in the literature (2-4), suggest that a criterion of not more than 1.0 ng of endotoxin (referenced to lot EC-2), which is the TPD, per the highest recommended human dose or USP pyrogen test dose per kg of body weight, whichever dose is the more stringent, is a logical choice to limit the quantity of bacterial endotoxin in small-volume parenteral products. 
